3138 results for «740»

Filter By

3138 results

Nurses and allied professionals abstracts session

20 May 2025 – From EuroPCR 2025

Highlight the pivotal role of nurses and allied health professionals in interventional cardiology through a series of abstracts addressing radial haemostasis, TAVI nursing programs, early mobilization, radiation protection, and physiologist-led intracoronary thermodilution assessments.

Nurses and allied professionals abstracts session

How to manage coronary artery disease in TAVI candidates?

20 May 2025 – From EuroPCR 2025

Understand the comprehensive management of coronary artery disease (CAD) in patients undergoing transcatheter aortic valve implantation (TAVI). This session reviews evidence-based evaluation, decision-making, and treatment strategies for significant coronary lesions, including severe left main and multivessel disease, illustrated through detailed case studies.

How to manage coronary artery disease in TAVI candidates?

My approach for a calcified bifurcation lesion

20 May 2025 – From EuroPCR 2025

This session provides a comprehensive approach to managing calcified bifurcation lesions. Learn how to interpret angiographic and intravascular imaging, plan interventions with appropriate devices for simplicity and safety, and evaluate final results to understand their clinical impact through real cases.

My approach for a calcified bifurcation lesion

Insights into emerging prognostic predictors for patients with coronary artery disease

20 May 2025 – From EuroPCR 2025

Gain insights into emerging prognostic predictors for coronary artery disease patients, including endothelial shear stress as a cardiovascular risk marker, impacts of intravascular imaging stratified by disease pattern, correlations between diastolic blood pressure and SYNTAX score, and long-term wall shear stress risk prediction from the FAME...

Insights into emerging prognostic predictors for patients with coronary artery disease

STEMI - What if a culprit lesion is not identifiable?

20 May 2025 – From EuroPCR 2025

Address challenging STEMI cases where culprit lesions are not immediately identifiable. This session emphasizes the utility of intravascular imaging in guiding decision-making and optimizing percutaneous interventions through illustrative cases involving left main stenosis, ambiguous culprit lesions, and etiological dilemmas in coronary occlusion.

STEMI - What if a culprit lesion is not identifiable?

How should I treat this vulnerable plaque?

21 May 2025 – From EuroPCR 2025

Learn to identify and manage vulnerable plaque using intracoronary imaging. This session covers detection techniques, clinical implications, current evidence for treatment, and case-based insights to improve patient outcomes through targeted intervention.

How should I treat this vulnerable plaque?

Treatment and prognostic stratification of ACS patients with cardiogenic shock

21 May 2025 – From EuroPCR 2025

This session focuses on treatment and prognostic stratification in ACS patients complicated by cardiogenic shock. Topics include mechanical CPR device performance, SCAI shock grade dynamics, hemorrhagic event predictors, ECMO-related strategies, and evaluation of BCIS conveyance algorithms for out-of-hospital cardiac arrest.

Treatment and prognostic stratification of ACS patients with cardiogenic shock

When coronary angiography is not enough

20 May 2025 – From EuroPCR 2025

Dive into the complexities that arise when coronary angiography alone is insufficient. This session explores comprehensive physiology and imaging assessments in INOCA with ventricular fibrillation, repeat coronary events, acetylcholine testing for epicardial spasm, and invasive physiology to stratify angina therapy.

When coronary angiography is not enough

DCB in de novo lesions: new valid option?

20 May 2025 – From EuroPCR 2025

Explore the emerging role of drug-coated balloons (DCB) in treating de novo coronary lesions. This session discusses complexity management, comparisons with drug-eluting stents (DES), and the potential of DCBs as valuable alternatives, especially in high bleeding risk patients.

DCB in de novo lesions: new valid option?

How a new generation of coronary sinus reducer can significantly expand treatment options for patients with coronary microvascular dysfunction

21 May 2025 – From EuroPCR 2025

Discover the latest on managing coronary microvascular dysfunction (CMD) with insights from EuroPCR 2025. This session explores how physiology testing helps identify CMD endotypes in the cathlab and highlights the limitations of ETT for patients experiencing angina or dyspnea at rest. Learn about the A-FLUX coronary...

How a new generation of coronary sinus reducer can significantly expand treatment options for patients with coronary microvascular dysfunction

Best companion's case on complications for stable coronary artery disease PCI: episode 1

20 May 2025 – From EuroPCR 2025

This session focuses on managing complications during PCI for stable coronary artery disease through real-world case presentations. Topics include severe dissections, unexpected procedural complications, and escalation of routine interventions, providing practical insights for complication navigation.

Best companion's case on complications for stable coronary artery disease PCI: episode 1

TAVI - Procedural complications

20 May 2025 – From EuroPCR 2025

Review procedural complications encountered during TAVI, including rare adverse events, management of balloon rupture, annulus rupture with tamponade, and unexpected intraoperative challenges. Gain insights into innovative rescue techniques and decision-making under critical conditions.

TAVI - Procedural complications

Advanced mitral valve TEER echocardiography

29 Sep 2025 – From PCR Gulf Valves 2025

Delve into advanced echocardiographic techniques for mitral valve TEER in this session. Gain expert knowledge on transseptal access, managing complex anatomical challenges, and practical strategies to navigate difficult and high-risk TEER procedures effectively.

Step-by-step TAVI for mixed bicuspid aortic valve disease - LIVE Case

30 Sep 2025 – From PCR Gulf Valves 2025

A 65-year-old female with a history of diabetes and moderate left ventricular dysfunction (LVEF 50%) presented with symptomatic severe bicuspid aortic stenosis associated with moderate-to-severe aortic regurgitation. A 26 mm Sapien Resilia valve was implanted under local anesthesia via femoral artery access, with right radial secondary...

Step-by-step TAVI for mixed bicuspid aortic valve disease - LIVE Case

Transseptal puncture workshop

30 Sep 2025 – From PCR Gulf Valves 2025

This workshop provides an in-depth understanding of transseptal puncture, focusing on interatrial septum anatomy, echocardiographic guidance, and complication avoidance. It is designed to enhance procedural safety and efficacy for interventional cardiologists performing transseptal access.

Intervening in aortic regurgitation: are we finally there?

30 Sep 2025 – From PCR Gulf Valves 2025

Explore the evolving landscape of transcatheter treatment for aortic regurgitation in this informative session. Understand the anatomical and clinical criteria essential for selecting candidates for transcatheter therapy, review the latest device options supported by real-world and investigational data, and learn to navigate procedural challenges with advanced...

Intervening in aortic regurgitation: are we finally there?

Second valve strategies with SAPIEN 3 Ultra RESILIA

30 Sep 2025 – From PCR Gulf Valves 2025

Gain key insights into managing second valve interventions with the SAPIEN 3 Ultra RESILIA system.
This session helps you anticipate and address complex scenarios such as mitral valve-in-valve, TAV-in-SAV, and valve-in-valve-in-valve procedures. Learn from expert case discussions that explore procedural strategies, technical challenges, and best practices to...

Second valves strategies with SAPIEN 3 Ultra RESILIA - Regional insights

Complex femoral access for TAVI in bicuspid aortic stenosis - LIVE Case

30 Sep 2025 – From PCR Gulf Valves 2025

A 74-year-old male with a history of multiple PCIs, peripheral arterial disease, and type 2 DM presented with symptomatic bicuspid aortic stenosis and preserved LV function.

A 26 mm Myval valve was implanted via right femoral artery access, with right radial secondary access, following predilatation with a...

Complex femoral access for TAVI in bicuspid aortic stenosis - LIVE Case

Echocardiography for mitral valvuloplasty ballooning

30 Sep 2025 – From PCR Gulf Valves 2025

Enhance your expertise in echocardiography assessment and intraprocedural guidance for mitral valvuloplasty ballooning. This session focuses on evaluating mitral stenosis, distinguishing suitable from non-suitable candidates, and offers practical, hands-on experience to optimize procedural outcomes using echocardiographic techniques.

Mitral valve TEER echocardiography

29 Sep 2025 – From PCR Gulf Valves 2025

Gain essential knowledge in mitral valve TEER echocardiography through this comprehensive session focused on key echocardiographic views, image optimization for screening, criteria for suitability, and intraprocedural guidance. Enhance your skills with practical hands-on components aimed at improving procedural outcomes.

Didn’t find what you were looking for?